Lexicon Pharmaceuticals (LXRX) Capital Expenditures Growth (3y) (2013 - 2024)
Lexicon Pharmaceuticals (LXRX) Capital Expenditures Growth (3y) (2013 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 888.49 Mn | 717.83 Mn | 20.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 174.17% |
| Sep 30, 2024 | 12.96% |
| Jun 30, 2024 | -35.85% |
| Sep 30, 2023 | 35.99% |
| Mar 31, 2022 | 2.78% |
| Dec 31, 2021 | -14.66% |
| Sep 30, 2021 | 314.08% |
| Jun 30, 2021 | 298.19% |
| Mar 31, 2021 | -1.70% |
| Dec 31, 2020 | 138.11% |
| Sep 30, 2020 | -18.52% |
| Mar 31, 2019 | 9.04% |
| Dec 31, 2018 | -46.82% |
| Sep 30, 2018 | -74.64% |
| Jun 30, 2018 | -68.12% |
| Mar 31, 2018 | 33.01% |
| Dec 31, 2017 | -51.00% |
| Sep 30, 2017 | 105.78% |
| Jun 30, 2017 | 86.19% |
| Mar 31, 2017 | 48.67% |